The retail giant is teaming up with Clover Health to market Medicare Advantage plans in eight counties in Georgia.
Walmart is poised to branch out even further into the healthcare sector with today’s announcement that it is partnering with Clover Health to offer Medicare Advantage plans in eight counties in northeastern Georgia next year.
Today’s Medicare Advantage announcement comes two week after a September 17 blog post by Lori Flees, senior vice president and chief operating officer of Walmart Health and Fitness, about the retailer’s expansion plans for its Walmart Health centers. Flees wrote that the giant retailer plans to open seven more of the health centers in Georgia this year, which would bring the total in the state to 12, and also two in the Chicago.
Lori Flees
The new Medicare Advantage plans will be called “Live Healthy: Clover Powered, Walmart Enhanced (PPO)”, and “Live Healthy LI: Clover Powered, Walmart Enhanced (PPO)." A Clover spokesperson said that The LiveHealthy LI plan is for people who might qualify for a low-income subsidy that will lower their prescription costs and add benefits. Today’s press release, which came from Clover, says the company’s proprietary software, called Clover Assistant, will support providers at the Walmart Health centers with data, clinical guidelines and machine learning “to surface the most urgent patient needs.”
"The Walmart brand is synonymous with the best value and low prices, and that's exactly what we're doing at Clover," said Andrew Toy, president and CTO of Clover Health, said in the press release.
Andrew Toy
The news of the Walmart-Clover Medicare Advantage came amid a flurry of reports about companies expanding the number off counties where they are selling Medicare Advantage plans.
Positive Results for Ruxolitinib Cream in Children with Atopic Dermatitis Presented in Ongoing Study
March 18th 2024Ruxolitinib cream showed positive results in children 2- to 11-years-old with mild to moderate atopic dermatitis (AD), according to data of a poster presented at the American Academy of Dermatology Annual Meeting in San Diego from March 8 to 12.
Read More
FDA Updates for Week of March 11: First CAR-T for CLL/SLL and First NASH Treatment
March 16th 2024The FDA this week approved a few firsts: the first treatment for NASH and the first CAR-T cell therapy for CLL/SLL. Other approvals include Tevimbra for esophageal cancer; Livmarli for second liver disease indication; and Praluent for children with genetic form of high cholesterol. The FDA also issued a CRL for monthly MS drug. Additionally, Celltrion submitted an application for an interchangeable Xolair biosimilar.
Read More
A Deep Dive into Predictive and Generative AI with Lynn Carroll of HSBlox
January 3rd 2024In this month’s episode, Briana Contreras, an editor of MHE, chatted with Lynn Carroll, executive of HSBlox, about the difference between predictive and generative AI, yet how each works together in preventive healthcare.
Listen
Transforming the management of genetic testing
March 15th 2024This e-book will explain where the current genetic test management system is inadequate and how a new approach designed specifically for genetic testing will perform better and provide more meaningful and actionable results.
Read More